Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Duranti

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Urology|June 23, 2017
Editorial CommentSergio Bracarda, Simona Duranti, Giandomenico Roviello
Expert Opinion on Emerging Drugs|February 1, 2012
Emerging drugs for small cell lung cancer--an updateGiulio Metro, Simona Duranti, Matthias Joachim Fischer, et al.
Frontiers in Oncology|September 20, 2021
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk AssessmentCamilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.
Cancers|April 30, 2021
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical DataSimona Duranti, Antonella Pietragalla, Gennaro Daniele, et al.
Expert Opinion on Investigational Drugs|January 11, 2021
Oregovomab: an investigational agent for the treatment of advanced ovarian cancerAntonella Pietragalla, Simona Duranti, Gennaro Daniele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion geneRita Chiari, Simona Duranti, Vienna Ludovini, et al.
Clinical Colorectal Cancer|October 16, 2014
Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysisStefania Gori, Gianluigi Lunardi, Alessandro Inno, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Frontiers in Oncology|May 14, 2026
Hereditary cancer syndromes with gynecological cancer risk: focus on prevention strategiesSimona Duranti, Valentina Iacobelli, Rita Trozzi, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 17, 2025
Clinical features and surgical options of obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome: A systematic review and a meta-analysis of prevalenceEmma Bonetti, Gloria Anderson, Simona Duranti, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Urology|June 23, 2017
Editorial CommentSergio Bracarda, Simona Duranti, Giandomenico Roviello
Expert Opinion on Emerging Drugs|February 1, 2012
Emerging drugs for small cell lung cancer--an updateGiulio Metro, Simona Duranti, Matthias Joachim Fischer, et al.
Frontiers in Oncology|September 20, 2021
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk AssessmentCamilla Nero, Francesca Ciccarone, Antonella Pietragalla, et al.
Cancers|April 30, 2021
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical DataSimona Duranti, Antonella Pietragalla, Gennaro Daniele, et al.
Expert Opinion on Investigational Drugs|January 11, 2021
Oregovomab: an investigational agent for the treatment of advanced ovarian cancerAntonella Pietragalla, Simona Duranti, Gennaro Daniele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Long-term response to gefitinib and crizotinib in lung adenocarcinoma harboring both epidermal growth factor receptor mutation and EML4-ALK fusion geneRita Chiari, Simona Duranti, Vienna Ludovini, et al.
Clinical Colorectal Cancer|October 16, 2014
Pharmacokinetics of oxaliplatin in a hemodialyzed patient: chemotherapy dose adjustment and timing of dialysisStefania Gori, Gianluigi Lunardi, Alessandro Inno, et al.
Clinical Breast Cancer|August 27, 2016
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer PatientsJennifer Foglietta, Alessandro Inno, Francesca de Iuliis, et al.
Frontiers in Oncology|May 14, 2026
Hereditary cancer syndromes with gynecological cancer risk: focus on prevention strategiesSimona Duranti, Valentina Iacobelli, Rita Trozzi, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 17, 2025
Clinical features and surgical options of obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome: A systematic review and a meta-analysis of prevalenceEmma Bonetti, Gloria Anderson, Simona Duranti, et al.
Pageof 4